Financing round-up: HAYA Therapeutics, Reliance Health, Vensica, CroíValve, Ribbon Biolabs

Austria: Ribbon Biolabs, a DNA synthesis company, has closed a €18m Series A funding round led by Hadean Ventures, with participation from Lansdowne Partners and Helicase Venture as well as undisclosed investors. Existing investors IST cube and tecnet equity also joined in the round. Funds will be used for the commercialization of Ribbon Biolabs’ DNA…

You must be a HMI Subscriber to view this content.

Subscribe Now »